The results demonstrated a significant association (P = 0.001) between higher WHO grades (grade III and grade IV) and increased TMUB1 expression, indicating that more advanced glioma grades were associated with elevated TMUB1 mRNA levels. The gene discussed is TMUB1; the disease is central nervous system cancer.